The global biotechnology market was worth USD 1.68 trillion in 2024 and is expected to surge around USD 3.54 Trillion by 2033, with a noteworthy CAGR of 9.18% from 2024 to 2033. The growing demand for ...

VS Mani, CFO of Glenmark Pharma, discusses the company's strong performance in FY25 with an average of Rs 1,100 crore per ...

Beijing-based pharma, BeiGene’s Brukinsa (zanubrutinib) has been approved by the US Food and Drug Administration (FDA) for chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL).

BeiGene has said it intends to resubmit the drug for use by NHS Scotland. The recommendations come 10 months after Brukinsa was approved by the Medicines and Healthcare products Regulatory Agency ...

Plant genetics deals with heredity in plants, specifically mechanisms of hereditary transmission and variation of inherited characteristics. Plant genetics differs from animal genetics in a number ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.

Feb. 11, 2025 — Colorado's forests store a massive amount of carbon, but dying trees -- mostly due to insects and disease -- have caused the state's forests to emit more carbon than they ...

DiveWire guarantees visibility for your news announcements through instant distribution to BioPharma Dive’s audience and its 176,000 newsletter subscribers for 21 days.